These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7157833)

  • 61. Pharmacokinetics and metabolism of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-α-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame) in the rat, dog, and man.
    Ubukata K; Nakayama A; Mihara R
    Food Chem Toxicol; 2011 Nov; 49 Suppl 1():S8-29. PubMed ID: 22036030
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The disposition and metabolism of 5-(4,5-dihydro-2-phenylbenz[e]indol-3-yl)salicylic acid (fendosal) in the rat, mouse, rabbit, do, rhesus monkey, and man.
    Warrander A; Metcalf R; Fromson JM
    Drug Metab Dispos; 1981; 9(2):161-7. PubMed ID: 6113117
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The physiological disposition and metabolism of enalapril maleate in laboratory animals.
    Tocco DJ; deLuna FA; Duncan AE; Vassil TC; Ulm EH
    Drug Metab Dispos; 1982; 10(1):15-9. PubMed ID: 6124377
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Metabolic fate of a new dihydropyridine calcium antagonist, CD-349, in rat and dog.
    Ogawa N; Mizuno K; Fukushima K; Suwa T; Satoh T
    Xenobiotica; 1993 Jul; 23(7):747-59. PubMed ID: 8237057
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine in rats, dogs, and monkeys.
    Hucker HB; Hutt JE; White SD; Arison BH; Zacchei AG
    Drug Metab Dispos; 1983; 11(1):54-8. PubMed ID: 6132797
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Absorption, metabolism and excretion of safrole in the rat and man.
    Benedetti MS; Malnoë A; Broillet AL
    Toxicology; 1977 Feb; 7(1):69-83. PubMed ID: 14422
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetics of amezinium in rat and dog.
    Traut M; Brode E; Neumann B; Kummer H
    Arzneimittelforschung; 1981; 31(9a):1594-604. PubMed ID: 7197974
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Disposition and urinary metabolic pattern of cabergoline, a potent dopaminergic agonist, in rat, monkey and man.
    Battaglia R; Strolin Benedetti M; Mantegani S; Castelli MG; Cocchiara G; Dostert P
    Xenobiotica; 1993 Dec; 23(12):1377-89. PubMed ID: 7907829
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Metabolism of 2-amino-3-methylimidazo[4,5-f]quinoline in the male rat.
    Inamasu T; Luks H; Vavrek MT; Weisburger JH
    Food Chem Toxicol; 1989 Jun; 27(6):369-76. PubMed ID: 2792966
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Species differences in the metabolism of sulphadimethoxine.
    Bridges JW; Kibby MR; Walker SR; Williams RT
    Biochem J; 1968 Oct; 109(5):851-6. PubMed ID: 4972257
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metabolism of carprofen, a nonsteroid anti-inflammatory agent, in rats, dogs, and humans.
    Rubio F; Seawall S; Pocelinko R; DeBarbieri B; Benz W; Berger L; Morgan L; Pao J; Williams TH; Koechlin B
    J Pharm Sci; 1980 Nov; 69(11):1245-53. PubMed ID: 7452450
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biliary excretion and enterohepatic circulation of paracetamol in the rat.
    Siegers CP; Rozman K; Klaassen CD
    Xenobiotica; 1983 Oct; 13(10):591-6. PubMed ID: 6673372
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Excretion and metabolism of flunarizine in rats and dogs.
    Meuldermans W; Hendrickx J; Hurkmans R; Swysen E; Woestenborghs R; Lauwers W; Heykants J
    Arzneimittelforschung; 1983; 33(8):1142-51. PubMed ID: 6685491
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The metabolic disposition of etodolac in rats, dogs, and man.
    Cayen MN; Kraml M; Ferdinandi ES; Greselin E; Dvornik D
    Drug Metab Rev; 1981; 12(2):339-62. PubMed ID: 6461537
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Assessment of enterohepatic circulation of radioactivity following a single dose of [14C]nimodipine in the rat.
    Suwelack D; Weber H
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):231-9. PubMed ID: 4085524
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
    Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Absorption, metabolism and excretion of pictilisib, a potent pan-class I phosphatidylinositol-3-Kinase (PI3K) inhibitor, in rats, dogs, and humans.
    Yue Q; Khojasteh SC; Cho S; Ma S; Mulder T; Chen J; Pang J; Ding X; Deese A; Pellet JD; Siebers N; Joas L; Salphati L; Ware JA
    Xenobiotica; 2021 Jul; 51(7):796-810. PubMed ID: 33938357
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Biochemical studies with oxitropium bromide. 1. Pharmacokinetics and metabolism in the rat and dog].
    Wahl D; Förster HJ; Pook KH; Richter I
    Arzneimittelforschung; 1985; 35(1A):255-65. PubMed ID: 4039166
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
    Tokuma Y; Fujiwara T; Noguchi H
    Xenobiotica; 1987 Nov; 17(11):1341-9. PubMed ID: 3433803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.